Imiquimod



Indications and Reactions:

Role Indications Reactions
Primary
Actinic Keratosis 20.9%
Genital Herpes 10.5%
Basal Cell Carcinoma 9.3%
Product Used For Unknown Indication 8.7%
B-cell Unclassifiable Lymphoma Low Grade 8.1%
Precancerous Skin Lesion 7.6%
Anogenital Warts 5.8%
Hypertension 5.8%
Hormone Replacement Therapy 3.5%
Skin Papilloma 3.5%
Atrial Fibrillation 2.3%
Haemangioma Of Skin 2.3%
Blood Pressure 1.7%
Blood Pressure Abnormal 1.7%
Hyperkeratosis 1.7%
Squamous Cell Carcinoma 1.7%
Arthralgia 1.2%
Blood Cholesterol 1.2%
Cheilitis 1.2%
Headache 1.2%
Rash 12.8%
Application Site Pain 6.4%
Drug Ineffective 6.4%
Pain 6.4%
Skin Exfoliation 6.4%
Application Site Pruritus 4.3%
Dizziness 4.3%
Drug Ineffective For Unapproved Indication 4.3%
Haemodialysis 4.3%
Hypotension 4.3%
Off Label Use 4.3%
Overdose 4.3%
Pneumonia 4.3%
Pulmonary Embolism 4.3%
Pyrexia 4.3%
Skin Reaction 4.3%
Treatment Noncompliance 4.3%
Vomiting 4.3%
Wound Secretion 4.3%
Altered State Of Consciousness 2.1%
Secondary
Cutaneous Sarcoidosis 17.5%
Precancerous Skin Lesion 14.2%
Hypertension 11.7%
Hyperkeratosis 9.2%
Basal Cell Carcinoma 8.3%
Product Used For Unknown Indication 6.7%
Hormone Replacement Therapy 5.0%
Actinic Keratosis 4.2%
Headache 3.3%
Anogenital Warts 2.5%
Pain 2.5%
Psoriasis 2.5%
Renal Transplant 2.5%
Cheilitis 1.7%
Crohn's Disease 1.7%
Psoriatic Arthropathy 1.7%
Skin Cancer 1.7%
Squamous Cell Carcinoma 1.7%
Atrial Fibrillation 0.8%
Bowen's Disease 0.8%
Application Site Inflammation 17.9%
Wrong Technique In Drug Usage Process 10.7%
Drug Ineffective 7.1%
Pancytopenia 7.1%
Application Site Pruritus 3.6%
Application Site Scar 3.6%
Application Site Ulcer 3.6%
Basal Cell Carcinoma 3.6%
Hypotension 3.6%
Infected Skin Ulcer 3.6%
Myocardial Infarction 3.6%
Osteonecrosis 3.6%
Papilloma Viral Infection 3.6%
Pemphigus 3.6%
Sarcoidosis 3.6%
Skin Exfoliation 3.6%
Skin Lesion 3.6%
Skin Reaction 3.6%
Skin Ulcer 3.6%
Social Problem 3.6%
Concomitant
Hiv Infection 24.3%
Behcet's Syndrome 14.8%
Drug Use For Unknown Indication 14.8%
Product Used For Unknown Indication 9.2%
Hypertension 4.6%
Anogenital Warts 4.2%
Immunosuppression 3.9%
Prophylaxis 3.5%
Actinic Keratosis 2.1%
Asthma 2.1%
Neuropathy Peripheral 2.1%
Affective Disorder 1.8%
Epilepsy 1.8%
Hypertonic Bladder 1.8%
Schizoaffective Disorder 1.8%
Tremor 1.8%
Acquired Immunodeficiency Syndrome 1.4%
Constipation 1.4%
Hepatitis C 1.4%
Multiple Sclerosis 1.4%
Immune Reconstitution Inflammatory Syndrome 6.7%
Muscle Rupture 6.7%
Osteomyelitis 6.7%
Platelet Count Decreased 6.7%
Pyrexia 6.7%
Salivary Gland Pain 6.7%
Sepsis 6.7%
Squamous Cell Carcinoma Of Skin 6.7%
Trichostasis Spinulosa 6.7%
Vomiting 6.7%
Angina Pectoris 3.3%
Anogenital Warts 3.3%
Application Site Scab 3.3%
Basal Cell Carcinoma 3.3%
Blood Testosterone Increased 3.3%
Blood Urea Increased 3.3%
Brain Stem Haemorrhage 3.3%
Breast Cancer 3.3%
C-reactive Protein Increased 3.3%
Cerebellar Atrophy 3.3%
Interacting
Atrial Fibrillation 25.0%
Basal Cell Carcinoma 25.0%
Crohn's Disease 25.0%
Drug Use For Unknown Indication 25.0%
International Normalised Ratio Increased 33.3%
Local Reaction 33.3%
Pancytopenia 33.3%